Lungpacer Overview
- Year Founded
-
2009

- Status
-
Private
- Employees
-
42

- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$20M
- Investors
-
15
Lungpacer General Information
Description
Manufacturer of therapy devices intended for the treatment of diaphragm muscle in critically ill patients who require mechanical ventilation. The company's diaphragm therapy system uses the body's nervous system to send messages to the diaphragm muscle to the source of natural breathing and provides repetitive exercises to rebuild diaphragm muscle strength critical to healthy breathing, enabling patients to prevent and reverse muscle-disuse atrophy and maintain diaphragmatic endurance.
Contact Information
Website
www.lungpacer.comCorporate Office
- 601 West Cordova Street
- Suite 130
- Vancouver, British Columbia V6B 1G1
- Canada
Corporate Office
- 601 West Cordova Street
- Suite 130
- Vancouver, British Columbia V6B 1G1
- Canada
Lungpacer Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
13. Later Stage VC (Series B) | 06-Apr-2022 | $20M | Completed | Clinical Trials - General | ||
12. Later Stage VC (Series B) | 22-Dec-2020 | Completed | Clinical Trials - General | |||
11. Later Stage VC (Series 2) | 07-Aug-2019 | Completed | Clinical Trials - General | |||
10. Later Stage VC (Series B) | 30-Apr-2019 | Completed | Clinical Trials - General | |||
9. Accelerator/Incubator | 01-Jun-2018 | Completed | Clinical Trials - General | |||
8. Later Stage VC | 01-Jan-2018 | Completed | Clinical Trials - General | |||
7. Later Stage VC (Series A) | 27-Apr-2017 | Completed | Clinical Trials - General | |||
6. Accelerator/Incubator | 26-Nov-2013 | Completed | Startup | |||
5. Grant | 28-Mar-2013 | $160K | $245K | Completed | Startup | |
4. Grant | 14-Apr-2010 | $170K | $245K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Lungpacer Patents
Lungpacer Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230023475-A1 | Systems and methods for stimulation | Pending | 13-Jan-2020 | ||
EP-4090413-A1 | Systems and methods for stimulation | Pending | 13-Jan-2020 | ||
EP-4090413-A4 | Systems and methods for stimulation | Pending | 13-Jan-2020 | ||
US-20200391027-A1 | Circuitry for medical stimulation systems | Active | 12-Jun-2019 | ||
EP-3983057-A4 | Circuitry for medical stimulation systems | Pending | 12-Jun-2019 | A61N1/3601 |
Lungpacer Signals
Lungpacer Investors (15)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
WJFS | Family Office | Minority | ||
4CGE | Venture Capital | Minority | ||
KCK MedTech | Venture Capital | Minority | ||
New Enterprise Associates | Venture Capital | Minority | ||
MedTech Innovator | Accelerator/Incubator | Minority |
Lungpacer FAQs
-
When was Lungpacer founded?
Lungpacer was founded in 2009.
-
Where is Lungpacer headquartered?
Lungpacer is headquartered in Vancouver, Canada.
-
What is the size of Lungpacer?
Lungpacer has 42 total employees.
-
What industry is Lungpacer in?
Lungpacer’s primary industry is Therapeutic Devices.
-
Is Lungpacer a private or public company?
Lungpacer is a Private company.
-
What is Lungpacer’s current revenue?
The current revenue for Lungpacer is
. -
How much funding has Lungpacer raised over time?
Lungpacer has raised $205M.
-
Who are Lungpacer’s investors?
WJFS, 4CGE, KCK MedTech, New Enterprise Associates, and MedTech Innovator are 5 of 15 investors who have invested in Lungpacer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »